Empowered Funds Portfolio holdings
Empowered Funds, which does business as ETF Architect, offers a ready-made ETF platform for fund managers, advisers and family offices, and runs its own ETFs on the same platform. Its specialty is tax-free exchanges, which it has used to move managed accounts, hedge funds and mutual funds into ETFs. The firm began operating as an investment adviser in 2014 and is wholly owned by Alpha Architect, which was founded by Wesley Gray, a former finance professor at Drexel University.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$170M |
| 2 |
NVIDIA
NVDA
|
+$124M |
| 3 |
Amazon
AMZN
|
+$89.6M |
| 4 |
Apple
AAPL
|
+$76.8M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$70.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$70.3M |
| 2 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$62.3M |
| 3 |
Roku
ROKU
|
+$36.8M |
| 4 |
TSMC
TSM
|
+$29.3M |
| 5 |
Citigroup
C
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.88% |
| 2 | Financials | 12.13% |
| 3 | Miscellaneous | 9.74% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Healthcare | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2376
Digimarc Corp
DMRC
$161M
| $128K | ﹤0.01% |
+22,000
| New | +$137K |
2026 Q3
0 quarters
|
|
2377
Ovid Therapeutics
OVID
$479M
| $128K | ﹤0.01% |
51,234
-40,000
| -44% | -$105K |
2026 Q1
2 quarters
|
|
2378
Kyverna Therapeutics
KYTX
$312M
| $127K | ﹤0.01% |
+18,683
| New | +$147K |
2026 Q3
0 quarters
|
|
2379
Flagstar Bank National Association
FLG
$4.17B
| $126K | ﹤0.01% |
10,819
+106
| +1% | +$1.46K |
2026 Q1
2 quarters
|
|
2380
PMV Pharmaceuticals
PMVP
$95.9M
| $126K | ﹤0.01% |
+75,575
| New | +$97.9K |
2026 Q3
0 quarters
|
|
2381
Transact Technologies
TACT
$50.1M
| $125K | ﹤0.01% |
+25,852
| New | +$133K |
2026 Q3
0 quarters
|
|
2382
Aardvark Therapeutics
AARD
$29.1M
| $124K | ﹤0.01% |
+23,602
| New | +$144K |
2026 Q3
0 quarters
|
|
2383
KULR Technology Group
KULR
$79.6M
| $124K | ﹤0.01% |
+49,152
| New | +$133K |
2026 Q3
0 quarters
|
|
2384
Neuraxis
NRXS
$76.9M
| $123K | ﹤0.01% |
+16,724
| New | +$111K |
2026 Q3
0 quarters
|
|
2385
United States Antimony
UAMY
$462M
| $123K | ﹤0.01% |
+29,498
| New | +$161K |
2026 Q3
0 quarters
|
|
2386
Comscore
SCOR
$45.7M
| $123K | ﹤0.01% |
+26,153
| New | +$160K |
2026 Q3
0 quarters
|
|
2387
Usio Inc
USIO
$58.2M
| $121K | ﹤0.01% |
+45,000
| New | +$108K |
2026 Q3
0 quarters
|
|
2388
BioAge Labs
BIOA
$255M
| $119K | ﹤0.01% |
+16,716
| New | +$232K |
2026 Q3
0 quarters
|
|
2389
Starfighters Space Inc
FJET
$50.8M
| $117K | ﹤0.01% |
+64,191
| New | +$217K |
2026 Q3
0 quarters
|
|
2390
Bridgford Foods
BRID
$49M
| $117K | ﹤0.01% |
+20,822
| New | +$129K |
2026 Q3
0 quarters
|
|
2391
Atara Biotherapeutics
ATRA
$78.5M
| $117K | ﹤0.01% |
+13,760
| New | +$125K |
2026 Q3
0 quarters
|
|
2392
Acrivon Therapeutics
ACRV
$62.1M
| $117K | ﹤0.01% |
+57,036
| New | +$108K |
2026 Q3
0 quarters
|
|
2393
Archer Aviation
ACHR
$3.15B
| $113K | ﹤0.01% |
22,763
+104
| +0.5% | +$566 |
2025 Q4
3 quarters
|
|
2394
Patriot National Bancorp
PNBK
$109M
| $113K | ﹤0.01% |
+122,940
| New | +$133K |
2026 Q3
0 quarters
|
|
2395
5E Advanced Materials
FEAM
$82.9M
| $113K | ﹤0.01% |
+33,557
| New | +$55K |
2026 Q3
0 quarters
|
|
2396
Alset
AEI
$20.6M
| $112K | ﹤0.01% |
147,147
+15,621
| +12% | +$18.5K |
2025 Q3
4 quarters
|
|
2397
Seritage Growth Properties
SRG
$85.6M
| $112K | ﹤0.01% |
+68,834
| New | +$154K |
2026 Q3
0 quarters
|
|
2398
Northern Technologies International Corp
NTIC
$72.4M
| $111K | ﹤0.01% |
+14,280
| New | +$115K |
2026 Q3
0 quarters
|
|
2399
Biomea Fusion
BMEA
$42.3M
| $111K | ﹤0.01% |
+83,219
| New | +$122K |
2026 Q3
0 quarters
|
|
2400
Flowers Foods
FLO
$1.17B
| $111K | ﹤0.01% |
19,912
-6,886
| -26% | -$49.2K |
2026 Q2
1 quarter
|
|
Similar funds
Empowered Funds's Q3 2026 Portfolio in Review
As of Q3 2026, Empowered Funds held 2,696 positions worth $21.7B, up 14% from $19B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Empowered Funds deployed $2.79B of net new capital in Q3 2026, opening 584 new positions and adding to 1,313 existing holdings. Its largest new stake was SK Hynix Inc: 193,851 shares worth $35.7M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Financials and Miscellaneous.
On the sell side, the largest reduction was Roku, an estimated $36.8M trimmed.
- Empowered Funds's largest Q3 2026 buy was SK Hynix Inc: 193,851 shares worth $35.7M.
- Empowered Funds added most to Microsoft in Q3 2026, an estimated $170M increase.
- Empowered Funds's biggest Q3 2026 reduction was Roku, cutting an estimated $36.8M.
- Empowered Funds fully exited Schwab Intermediately-Term US Treasury ETF in Q3 2026, selling an estimated $70.3M.
- Empowered Funds's ten largest holdings make up 19% of its $21.7B portfolio in Q3 2026.
- Empowered Funds opened 584 new positions and closed 184 in Q3 2026.
- Empowered Funds's portfolio value rose 14% quarter-over-quarter to $21.7B.
Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.